Circulation

publication venue for

NT-proBNP and Cardiac Troponin I, but Not Cardiac Troponin T, Are Associated With 7-Year Changes in Cardiac Structure and Function in Older Adults: The ARIC Study. 2024
Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".. 150:e25-e26. 2024
Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.. 150:867-883. 2024
Variation of NT-proBNP and High-Sensitivity Cardiac Troponin T Across Levels of Estimated Glomerular Filtration Rate: The SPRINT Trial.. 149:967-969. 2024
Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.. 149:e1051-e1065. 2024
Energetic Basis of Recovered Ejection Fraction in Human Heart Failure.. 148:1976-1978. 2023
Overcoming Challenges to Implementing New Evidence for Low-Dose Anticoagulant Use in Peripheral Artery Disease.. 148:1929-1931. 2023
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.. 149:825-838. 2023
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.. 149:204-216. 2023
Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis.. 149:293-304. 2023
Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations.. 149:430-449. 2023
Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug-Gene Networks: From Biology to Precision Therapeutics.. 148:1459-1478. 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).. 148:1113-1126. 2023
Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.. 147:1919-1932. 2023
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.. 148:220-228. 2023
Sarcopenia and Cardiovascular Diseases.. 147:1534-1553. 2023
Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure.. 147:1121-1133. 2023
Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry.. 147:1053-1063. 2023
Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.. 147:310-323. 2022
Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association.. 147:e32-e62. 2022
An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association.. 146:e558-e568. 2022
Advancing Peripheral Artery Disease Quality of Care and Outcomes Through Patient-Reported Health Status Assessment: A Scientific Statement From the American Heart Association.. 146:e286-e297. 2022
Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.. 146:1434-1443. 2022
Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States.. 146:1297-1309. 2022
Restoration of Cardiomyogenesis in Aged Mouse Hearts by Voluntary Exercise.. 146:-. 2022
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.. 146:657-672. 2022
Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.. 146:-. 2022
Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.. 145:-. 2022
Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.. 145:1308-1311. 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. 2022
Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts.. 145:268-278. 2021
Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries.. 145:110-121. 2021
Association Between Cervical Artery Dissection and Aortic Dissection.. 144:840-842. 2021
Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.. 144:615-637. 2021
Myocarditis Temporally Associated With COVID-19 Vaccination.. 144:502-505. 2021
Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.. 144:e16-e35. 2021
Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.. 143:2454-2470. 2021
Gender-Based Differences in Outcomes Among Resuscitated Patients With Out-of-Hospital Cardiac Arrest.. 143:641-649. 2020
Reduced Right Ventricular Sarcomere Contractility in Heart Failure With Preserved Ejection Fraction and Severe Obesity.. 143:965-967. 2020
Linear and Nonlinear Mendelian Randomization Analyses of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J-Curve Revisited.. 143:895-906. 2020
Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.. 142:2420-2430. 2020
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.. 143:120-134. 2020
Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.. 142:230-243. 2020
Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries.. 142:29-39. 2020
No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women.. 141:1110-1112. 2020
Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.. 141:1001-1026. 2020
Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial.. 141:1295-1306. 2020
Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.. 141:957-967. 2020
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association.. 141:e6-e32. 2019
HIV Infection Is Associated With Variability in Ventricular Repolarization: The Multicenter AIDS Cohort Study (MACS).. 141:176-187. 2019
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.. 140:2076-2088. 2019
Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates.. 140:1227-1230. 2019
Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.. 140:645-657. 2019
Noninferiority Designed Cardiovascular Trials in Highest-Impact Journals.. 140:379-389. 2019
Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.. 139:2892-2909. 2019
Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection.. 139:2003-2011. 2019
Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.. 139:1497-1506. 2019
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.. 139:e56-e528. 2019
Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction.. 139:1047-1056. 2019
Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement.. 138:2202-2211. 2018
Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.. 138:1951-1962. 2018
Alirocumab's Price Reduction.. 138:1502-1504. 2018
How Do Resuscitation Teams at Top-Performing Hospitals for In-Hospital Cardiac Arrest Succeed? A Qualitative Study.. 138:154-163. 2018
Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.. 137:2551-2553. 2018
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.. 137:e67-e492. 2018
Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.. 137:1814-1823. 2018
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.. 137:364-375. 2018
Association Between Prompt Defibrillation and Epinephrine Treatment With Long-Term Survival After In-Hospital Cardiac Arrest.. 137:2041-2051. 2017
Really. 136:2141-2143. 2017
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.. 136:2100-2116. 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.. 137:134-143. 2017
Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study.. 136:1451-1453. 2017
Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo.. 136:2271-2283. 2017
Physical Activity in Heart Failure With Preserved Ejection Fraction: Moving Toward a Newer Treatment Paradigm.. 136:993-995. 2017
Obese Heart Failure With Preserved Ejection Fraction Phenotype: From Pariah to Central Player.. 136:20-23. 2017
Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.. 135:2389-2402. 2017
Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.. 135:2119-2132. 2017
Sex Differences in 1-Year All-Cause Rehospitalization in Patients After Acute Myocardial Infarction: A Prospective Observational Study.. 135:521-531. 2017
High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).. 135:1494-1505. 2017
Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.. 135:1024-1035. 2017
An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.. 135:180-195. 2017
Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults: The Atherosclerosis Risk in Communities Study.. 135:426-439. 2016
Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.. 135:224-240. 2016
Medical Training to Achieve Competency in Lifestyle Counseling: An Essential Foundation for Prevention and Treatment of Cardiovascular Diseases and Other Chronic Medical Conditions: A Scientific Statement From the American Heart Association.. 134:e308-e327. 2016
Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population.. 134:806-16. 2016
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.. 134:441-50. 2016
Response by Peralta et al to Letter Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial".. 134:e26-7. 2016
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.. 134:73-90. 2016
Randomized, Controlled Trial of an Advance Care Planning Video Decision Support Tool for Patients With Advanced Heart Failure.. 134:52-60. 2016
Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.. 133:2141-8. 2016
Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial.. 133:1341-50. 2016
Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.. 133:584-91. 2016
Response to Letter Regarding Article, "Poorly Cited Articles in Peer-Reviewed Cardiovascular Journals from 1997 to 2007: Analysis of 5-Year Citation Rates".. 133:e23-4. 2016
Response to Letter Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet".. 132:e250-1. 2015
Dose-Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis.. 132:1786-94. 2015
FDA Policy and Cardiovascular Medicine.. 132:1136-45. 2015
The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Classification System: A Taxonomy for Young Women With Acute Myocardial Infarction.. 132:1710-8. 2015
Conventional Wisdom in Heart Failure Treatment Challenged Again: Does Heart Rate Lowering Worsen Exercise Intolerance in Heart Failure With Preserved Ejection Fraction?. 132:1687-9. 2015
Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction.. 132:158-66. 2015
The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association.. 131:1932-40. 2015
Poorly cited articles in peer-reviewed cardiovascular journals from 1997 to 2007: analysis of 5-year citation rates.. 131:1755-62. 2015
Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet.. 131:1061-70. 2015
What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction.. 131:522-4. 2014
Early adult to midlife cardiovascular risk factors and cognitive function.. 129:1560-7. 2014
Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis.. 129:1832-9. 2014
Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry.. 129:580-6. 2013
National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.. 128:2577-84. 2013
Variation exists in rates of admission to intensive care units for heart failure patients across hospitals in the United States.. 127:923-9. 2013
Catheter-induced venous spasm.. 126:2363-5. 2012
Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.. 126:1110-20. 2012
Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.. 126:1514-63. 2012
Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction.. 125:2751-61. 2012
Triggers of hospitalization for venous thromboembolism.. 125:2092-9. 2012
Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study.. 125:2316-22. 2012
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.. 126:1964-71. 2012
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction.. 124:2855-64. 2011
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.. 124:695-703. 2011
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT.. 123:2985-93. 2011
Chronotropic incompetence: causes, consequences, and management.. 123:1010-20. 2011
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association.. 122:406-41. 2010
Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.. 121:651-8. 2010
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.. 121:1382-92. 2010
Integrative predictive model of coronary artery calcification in atherosclerosis.. 120:2448-54. 2009
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.. 120:502-9. 2009
Recommendations for clinical exercise laboratories: a scientific statement from the american heart association.. 119:3144-61. 2009
Policy research: using evidence to improve healthcare delivery systems.. 119:891-8. 2009
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.. 119:940-51. 2009
N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.. 120:1768-74. 2009
Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery.. 119:229-36. 2008
Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study.. 117:2599-607. 2008
Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.. 116:2127-38. 2007
Images in cardiovascular medicine. Pseudoaneurysm and intracardiac fistula caused by an infected paclitaxel-eluting coronary stent.. 116:e364-5. 2007
Patterns of weight change preceding hospitalization for heart failure.. 116:1549-54. 2007
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.. 115:2533-9. 2007
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.. 115:584-92. 2007
Determinants of coronary artery and aortic calcification in the Old Order Amish.. 115:717-24. 2007
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography).. 115:402-26. 2007
Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals.. 116:2280-7. 2007
Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction.. 115:1012-9. 2007
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.. 115:173-9. 2006
Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.. 114:1293-300. 2006
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.. 113:1760-7. 2006
Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study.. 113:388-93. 2006
Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA).. 113:30-7. 2005
Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension.. 112:2403-10. 2005
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.. 112:1687-91. 2005
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.. 112:232-40. 2005
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.. 112:39-47. 2005
Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.. 111:21-9. 2004
Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history.. 110:2150-6. 2004
Predictors of heart failure among women with coronary disease.. 110:1424-30. 2004
Differences in medical care and disease outcomes among black and white women with heart disease.. 108:1089-94. 2003
Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.. 107:2799-804. 2003
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients?. 107:811-6. 2003
C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.. 107:245-50. 2003
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.. 107:87-92. 2003
Prevalence of significant noncardiac findings on electron-beam computed tomography coronary artery calcium screening examinations.. 106:532-4. 2002
Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart.. 105:2192-7. 2002
Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.. 105:457-61. 2002
Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging.. 104:1214-7. 2001
Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study.. 90:179-85. 1994
Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.. 86:1302-9. 1992
Association of New-Onset Atrial Fibrillation with the Development of Frailty in Older Veterans: A Propensity Matching Study 2021
Global Disparities of Hypertension Prevalence and Control 2016
Global Disparities of Hypertension Prevalence and Control 2016
Global Disparities of Hypertension Prevalence and Control 2016
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. 2016
Global disparities of hypertension prevalence and control 2016
Heart Disease and Stroke Statistics—2016 Update 2016
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials 2016
Executive Summary: Heart Disease and Stroke Statistics—2015 Update 2015
Heart Disease and Stroke Statistics—2015 Update 2015
Executive Summary: Heart Disease and Stroke Statistics—2013 Update 2013
Executive Summary: Heart Disease and Stroke Statistics—2013 Update 2013
A Challenging Case of Endocarditis-Multi-Disciplinary Approach is an Achievable Chimera 2021

Clin-STAR Database

Circulation Journal

Overview

publication venue for

Identity

International Standard Serial Number (ISSN)